To directly interrogate whether the distant tumor control induced by pre-resectional RFA was due to systemic adaptive immunity, we depleted CD8+ T cells by antibody treatment beginning at the time of RFA treatment and evaluated the impact on lung tumor outgrowth compared with the isotype antibody-treated control group (Fig 6A and 6D). This evidence concerns the gene CD8A and neoplasm.